Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Ten Haaf

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Journal of Epidemiology and Community Health|June 14, 2015
Overdiagnosis in lung cancer screening: why modelling is essentialKevin Ten Haaf, Harry J de Koning
Annals of Internal Medicine|August 8, 2018
Risk-Targeted Lung Cancer ScreeningSonya Cressman, Kevin Ten Haaf, Stephen Lam, et al.
Pharmacoeconomics|August 6, 2020
Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung CancerErik F Blom, Kevin Ten Haaf, Harry J de Koning
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2014
Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trialsKevin Ten Haaf, Joost van Rosmalen, Harry J de Koning
Lung Cancer (Amsterdam, Netherlands)|December 10, 2019
Trends in lung cancer risk and screening eligibility affect overdiagnosis estimatesErik F Blom, Kevin Ten Haaf, Harry J de Koning
Thorax|February 15, 2018
Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screeningKevin Ten Haaf, Carlijn M van der Aalst, Harry J de Koning
The Lancet. Respiratory Medicine|September 7, 2016
Lung cancer screening: latest developments and unanswered questionsCarlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
Translational Lung Cancer Research|March 15, 2021
Implementation of lung cancer screening: what are the main issues?Carlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
BMJ (Clinical Research Ed.)|December 30, 2017
Low dose CT screening for lung cancerDavid R Baldwin, Kevin Ten Haaf, Janette Rawlinson, et al.
BMJ Open Respiratory Research|May 15, 2020
Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer DatabaseErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Journal of Epidemiology and Community Health|June 14, 2015
Overdiagnosis in lung cancer screening: why modelling is essentialKevin Ten Haaf, Harry J de Koning
Annals of Internal Medicine|August 8, 2018
Risk-Targeted Lung Cancer ScreeningSonya Cressman, Kevin Ten Haaf, Stephen Lam, et al.
Pharmacoeconomics|August 6, 2020
Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung CancerErik F Blom, Kevin Ten Haaf, Harry J de Koning
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2014
Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trialsKevin Ten Haaf, Joost van Rosmalen, Harry J de Koning
Lung Cancer (Amsterdam, Netherlands)|December 10, 2019
Trends in lung cancer risk and screening eligibility affect overdiagnosis estimatesErik F Blom, Kevin Ten Haaf, Harry J de Koning
Thorax|February 15, 2018
Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screeningKevin Ten Haaf, Carlijn M van der Aalst, Harry J de Koning
The Lancet. Respiratory Medicine|September 7, 2016
Lung cancer screening: latest developments and unanswered questionsCarlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
Translational Lung Cancer Research|March 15, 2021
Implementation of lung cancer screening: what are the main issues?Carlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
BMJ (Clinical Research Ed.)|December 30, 2017
Low dose CT screening for lung cancerDavid R Baldwin, Kevin Ten Haaf, Janette Rawlinson, et al.
BMJ Open Respiratory Research|May 15, 2020
Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer DatabaseErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
Pageof 8